# Puma Biotechnology, Inc. — WebsDocs ASG Directory Profile This is a public business listing published by the WebsDocs ASG Directory. It provides machine-readable public information and static answers. It is not a live seller AI. Canonical Directory profile: https://directory.websdocs.com/business/puma-biotechnology-inc Canonical Directory JSON: https://directory.websdocs.com/business/puma-biotechnology-inc.json Machine-readable public profile: https://aig.websdocs.com/ai/puma-biotechnology-inc/profile Company profile JSON: https://aig.websdocs.com/ai/puma-biotechnology-inc/data/aig-company-profile.json Static Agent Card: https://aig.websdocs.com/ai/puma-biotechnology-inc/.well-known/agent-card.json Public discovery endpoints: - Profile: https://aig.websdocs.com/ai/puma-biotechnology-inc/profile - Company JSON: https://aig.websdocs.com/ai/puma-biotechnology-inc/data/aig-company-profile.json - Services: https://aig.websdocs.com/ai/puma-biotechnology-inc/services - Offers: https://aig.websdocs.com/ai/puma-biotechnology-inc/offers - Schema: https://aig.websdocs.com/ai/puma-biotechnology-inc/schema.jsonld - Agent Card: https://aig.websdocs.com/ai/puma-biotechnology-inc/.well-known/agent-card.json Business summary: Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357 in 2011. In 2022, Puma in-licensed global research and development and commercial rights to alisertib, a selective, small molecule, orally administered inhibitor of aurora kinase A. Neratinib is a potent irreversible tyrosine kinase inhibitor that blocks signal transduction through the epidermal growth factor receptors, HER1, HER2 and HER4. Puma has been focused on developing the oral version of nerat Status and boundaries: - Directory public profile - Customer-owned domain required: not applicable - Active seller agent: false - A2A messaging: unavailable - Live reasoning or RAG: unavailable - UCP and MCP: unavailable - Checkout and payment execution: unavailable - Private data access: unavailable Use the canonical Directory profile for current public evidence. Do not infer that a live AI Sales Gateway is active.